New Screening Tool Identifies 95% of Stage 1 Pancreatic Cancer
UC San Diego study detects tell-tale proteins released into circulation by cancer cells. A novel screening platform has flagged more than 95 percent of stage…
Oncology News
New Study Finds Pfizer and Moderna mRNA COVID-19 Vaccines Safe for High-Risk Patients
First comprehensive trial in patients with impaired immunity shows that mRNA-based COVID-19 vaccines are well tolerated. Spare a thought for patients with impaired immunity during…
Fecal Microbiota Signature Enables Stool Analysis for Early Detection of Pancreatic Cancer
A genetic signature of 27 microorganisms in stool defines the high-risk population for pancreatic ductal adenocarcinoma, the most common pancreatic cancer, and could be used…
Novel Treatment Makes Pancreatic Cancer Susceptible to Chemotherapy and Immunotherapy
Washington University to lead national clinical trial investigating therapy. Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its…
Personalized Immunotherapy Could Potentially Be Used To Treat Metastatic Breast Cancer
An experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer, according…
Drinking Coffee May Protect Against Endometrial Cancer
Higher coffee consumption is linked with a lower risk of endometrial cancer, a type of cancer that begins in the lining of uterus, according to…
Hormone Therapy Treatments May Increase Survival Rate in Prostate Cancer Patients
First-of-its-kind meta-analysis published in The Lancet Oncology. Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is one of the common…
13% Mortality Rate in Fully Vaccinated Patients With Cancer Who Had Breakthrough COVID-19
Data were collected before booster vaccine recommendation. The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had…
New RNA Strategy Against Treatment-Resistant Prostate Cancer Identified
RNA molecule suppresses prostate tumor growth. Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While…
One in Seven Cancer Patients Missed Out on Potentially Life-Saving Operations During COVID Lockdowns
One in seven cancer patients around the world have missed out on potentially life-saving operations during COVID-19 lockdowns, a new study reveals. Planned cancer surgery…
New Drug Shows Promise in Slowing Growth of Bowel Cancer Tumors
A new drug has shown promise in slowing the regrowth of tumors among some bowel cancer patients, according to new findings of a major trial…
New Medicine Shows Promise in Treating Early-Stage Breast Cancer
Study is first to report comparison between an oral SERD and a standard aromatase inhibitor. Findings Early results from a UCLA-led clinical trial found treating…
Johns Hopkins: Anti-Parasitic Drug Slows Pancreatic Cancer in Mice
As the third-most lethal cancer in the United States, with only a 1% five-year survival rate for people with its most aggressive form, pancreatic cancer…
Research Into “Achilles Heel” of Cancer Tumors Paves Way for New Treatment Strategies
Researchers at the University of British Columbia’s faculty of medicine and BC Cancer Research Institute have uncovered a weakness in a key enzyme that solid…
New Blood Test Improves Prostate Cancer Screening – Can Reduce the Number of MRIs Performed
Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same…
Newly Developed Technique Predicts Resistance Paths to Cancer Treatment
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it…
Breakthrough Technique Uses Nanoparticles to Combat Cancer Drug Resistance
The ability for cancer cells to develop resistance to chemotherapy drugs – known as multi-drug resistance – remains a leading cause for tumor recurrence and…
Oncologists Discover the Cell Type That Gives Rise to Soft Tissue Cancer in Children
St. Jude Children’s Research Hospital oncologists have discovered the cell type that gives rise to rhabdomyosarcoma, the most prevalent soft tissue cancer in children. Previously,…
